Which hedge funds own RNA? ATRIUM THERAPEUTICS INC, Q2 2026 13F holders
37 tracked hedge funds disclosed a position in RNA (ATRIUM THERAPEUTICS INC) in their Q2 2026 13F filings, worth $92.3m in total. The largest holder by portfolio weight is Crcm LP at 5.7% of its book. 9 opened a new position this quarter: Crcm LP, Trium Capital LLP, DAFNA Capital Management LLC, Anson Funds Management LP. 18 exited: Cannon Global Investment Management, LLC, Fifth Lane Capital, LP, O'Connor Alternative Investments LLC.
- 37
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 9
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 18
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $16.6m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $38.5m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $92.3m
- Combined value Sum of the holders' reported positions in the security.
- 3.0%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Cannon Global Investment Management, LLC | 0.8% | $335k |
| Fifth Lane Capital, LP | 0.6% | $481k |
| O'Connor Alternative Investments LLC | 0.4% | $7.7m |
| Quarry LP | 0.2% | $891k |
| RA Capital Management, L.P. | 0.1% | $11.6m |
| Fortress Investment Group LLC | 0.08% | $295k |
| Pentwater Capital Management LP | 0.06% | $8.1m |
| AlphaGrep UK Ltd | 0.05% | $159k |
| AQR Arbitrage LLC | 0.04% | $2.4m |
| Highbridge Capital Management LLC | 0.04% | $555k |
| Farallon Capital Management, L.L.C. | 0.03% | $4.7m |
| Diadema Partners LP | 0.01% | $33.6k |
| Centiva Capital, LP | 0.0% | $78.8k |
| Persistent Asset Partners Ltd | 0.0% | $3.8k |
| Woodline Partners LP | 0.0% | $386k |
| Magnetar Financial LLC | 0.0% | $141k |
| Point72 Asset Management, L.P. | 0.0% | $304k |
| Marshall Wace, LLP | 0.0% | $450k |
Ownership over time
Who discovered RNA first? Beta
| Arbiter Partners Capital Management LLC | Q1 2026 | 0.0 pts |
| Marble Bar Asset Management LLP | Q1 2026 | 0.0 pts |
| Creek Drive Management Group LLC | Q1 2026 | 0.0 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.